Federal R&D, Drug Discovery, and Pricing : Insights from NIH-University-Industry Relationship.
Explores reasons behind Government funding of R&D and subsequent efforts to facilitate private sector commercialization of the results of such work. Examines the manner in which NIH supports research to encourage the development of new pharmaceuticals and therapeutics through cooperative activit...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2004.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Explores reasons behind Government funding of R&D and subsequent efforts to facilitate private sector commercialization of the results of such work. Examines the manner in which NIH supports research to encourage the development of new pharmaceuticals and therapeutics through cooperative activities with academia, industry, and Government. Discusses whether or not use of the results of Federal R&D enterprise warrants Government input into price decisions made by the private sector. Addresses concerns surrounding innovation in health-related areas within the context of the Government's role in facilitating technological progress. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Nov. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |